Comment on FDA Approves Cholesterol Drug From Regeneron, Sanofi

FDA Approves Cholesterol Drug From Regeneron, Sanofi

Federal regulators approved the first of a new class of cholesterol-lowering medicines, developed by Regeneron and Sanofi. The drug, called Praluent, provides a new option for high-risk heart patients.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News